Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Minimizing Toxicity of Treatments for B Cell Lymphoma with Dr. Dan Gold MEI Pharma TRANSCRIPT
Download PDFDec 30, 2021
Dr. Dan Gold is the President and CEO of MEI Pharma and is tackling non-Hodgkin's B cell lymphoma to bring a therapy to patients minimizing the toxicities that are associated with current treatments. Their drug candidate zandelisib is a P13K delta inhibitor. It is being studied in lymphoma in B cells to determine if...
Dec 30, 2021
Dr. Dan Gold is the President and CEO of MEI Pharma and is tackling non-Hodgkin's B cell lymphoma to bring a therapy to patients minimizing the toxicities that are associated with current treatments. Their drug candidate zandelisib is a P13K delta inhibitor. It is being studied in lymphoma in B cells to determine if...
Expanding the Role of Virtual Care for Emergency Triage Treat and Transport with Justin Miller eVisit TRANSCRIPT
Download PDFDec 29, 2021
Justin Miller is the VP of Customer Success at eVisit and has recently returned from a tour of client sites to see how telehealth is functioning particularly in the real-world application of the Emergency Triage, Treat, and Transport (ET3) emergency medical response model. eVisit is the only end-to-end enterprise care...
Dec 29, 2021
Justin Miller is the VP of Customer Success at eVisit and has recently returned from a tour of client sites to see how telehealth is functioning particularly in the real-world application of the Emergency Triage, Treat, and Transport (ET3) emergency medical response model. eVisit is the only end-to-end enterprise care...
Developing Long COVID Fatigue Oral Treatment Using Endogenous Molecules with Bill Hinshaw Axcella Therapeutics TRANSCRIPT
Download PDFDec 28, 2021
Bill Hinshaw is the President and CEO of Axcella Therapeutics, a clinical-stage biotech company founded by Flagship Pioneering, Founder of Moderna. Using their platform to create compositions of endogenous metabolic modulators, EMMs, Axcella has generated two liver programs including 1125 for treating NASH. Preclinical...